Trial · NCT03233724
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Phase I Dose Escalation | STARTED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 2 | |
| Phase I Dose Escalation | STARTED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 2 | |
| Phase I Dose Escalation | STARTED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 4 | |
| Phase I Dose Escalation | STARTED | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | |
| Phase I Dose Escalation | STARTED | Enrolled to Revised Dose Level 1 But Not Treated | 1 | |
| Phase I Dose Escalation | COMPLETED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 1 | |
| Phase I Dose Escalation | COMPLETED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 1 | |
| Phase I Dose Escalation | COMPLETED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 1 | |
| Phase I Dose Escalation | COMPLETED | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | |
| Phase I Dose Escalation | COMPLETED | Enrolled to Revised Dose Level 1 But Not Treated | 0 | |
| Phase I Dose Escalation | NOT COMPLETED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 1 | |
| Phase I Dose Escalation | NOT COMPLETED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 1 | |
| Phase I Dose Escalation | NOT COMPLETED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 3 | |
| Phase I Dose Escalation | NOT COMPLETED | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | |
| Phase I Dose Escalation | NOT COMPLETED | Enrolled to Revised Dose Level 1 But Not Treated | 1 | |
| Phase II Dose Expansion | STARTED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 0 | |
| Phase II Dose Expansion | STARTED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 0 | |
| Phase II Dose Expansion | STARTED | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | |
| Phase II Dose Expansion | STARTED | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | |
| Phase II Dose Expansion | STARTED | Enrolled to Revised Dose Level 1 But Not Treated | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03233724/flow